Glaxo Seeks To Bar Testimony In Paxil Case
In court documents filed Thursday in the U.S. District Court for the Northern District of California, defendant SmithKline Beecham Corp. (which does business as GlaxoSmithKline) said that certain portions of the testimony of Dr. Joseph Glenmullen should be stricken and that the court should allow additional time to depose him.
“Dr. Glenmullen's frequently non-responsive testimony and...
To view the full article, register now.